UroToday6d
Navigating Cancer Care Costs Videos
A Complex Landscape of Out-of-Pocket Expenses - Benjamin Pockros ...
UroToday2d
ASTRO 2024 Featuring Validation of Digital Pathology MMAI Algorithm and of the Decipher® Genomic Testing in the VANDAAM Study
Yang Song presented findings on the ArteraAI Prostate Test, a digital pathology multimodal artificial intelligence (MMAI) algorithm, which was shown to predict overall survival in patients with ...
UroToday4d
2024 Revised Dutch guidelines for urinary incontinence: Addressing clinical bottlenecks through a modular approach
The Dutch Urological Association (NVU) has revised its guidelines for the treatment of urinary incontinence (UI) in secondary and tertiary care, updating the 2014 guidelines to address specific ...
UroToday4d
Does the Extent of Transurethral Resection after Radiation Therapy Impact Survival Outcomes in Muscle-Invasive Bladder Cancer - Expert Commentary
A current standard of care treatment for muscle-invasive bladder cancer (MIBC) is platinum-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC). Bladder-sparing protocols are ...
UroToday6d
When is prostate cancer really cancer?
Prostate cancer (PC) is a major cause of cancer-related deaths worldwide, with far more diagnoses than deaths annually. Recent discussions have challenged whether Grade Group 1 (GG1) PC should be ...
UroToday4d
Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor-immune microenvironment favoring response to immune checkpoint blockade.
Immune checkpoint blockade (ICB) is currently the standard of care for metastatic renal cell carcinoma (RCC), but treatment responses remain unpredictable. Aristolochic acid (AA), a prevalent ...
UroToday4d
Tranexamic Acid During Radical Cystectomy: A Randomized Clinical Trial.
Among cancer surgeries, patients requiring open radical cystectomy have the highest risk of red blood cell (RBC) transfusion. Prophylactic tranexamic acid (TXA) reduces blood loss during cardiac and ...
UroToday4d
Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis.
The value of pelvic lymph node irradiation is debated for patients with muscle-invasive bladder cancer (MIBC) undergoing curative-intent radiation therapy (RT). We sought to compare the oncological ...
UroToday4d
Multivariate analysis of the parameters affecting the choice of surgical treatment for patients with localized renal cell carcinoma (RCC).
to determine the key factors affecting the surgical treatment selection for patients with localized Renal-Cell Carcinoma (RCC) based on clinical and nephrometry data. A retrospective cohort study to ...
UroToday5d
Clear cell renal cell carcinoma micrometastasis: Insights from an unconventional cutaneous presentation.
Clear cell renal cell carcinoma (ccRCC) is a highly lethal cancer known for its propensity to metastasise, yet the mechanisms underlying metastasis are not well defined. Cutaneous metastases from ...
UroToday5d
The role of radical cystectomy and lymphadenectomy in the management of bladder cancer with clinically positive lymph node involvement.
The role of radical cystectomy and pelvic lymph node dissection in muscle-invasive bladder cancer (MIBC) with clinically positive lymph nodes is debated. This review examines the role of surgery in ...
UroToday4d
Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastases.
Metastases to the brain are rare in prostate cancer. Here, we describe a patient with two treatment-emergent metastatic lesions, one to the brain with neuroendocrine prostate cancer (NEPC) histology ...